Healthcare


Healthcare Publication

Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona

Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.

Launch of Ipsos PersonaBot, a groundbreaking AI-powered solution to enhance segmentation research

Ipsos has launched Ipsos PersonaBot. This AI-powered tool, powered by Ipsos Facto, allows organizations to engage in conversations with personas representing their target audience. Ipsos PersonaBot is available for both consumer and healthcare sectors.
Healthcare Publication

Brand Success in the GLP-1 Era

Harnessing Context, Empathy & Expectations.
Healthcare Publication

A Dose of Digital: Can Pharma Make DTx a Healthy Business?

Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
Mental health Survey

Data Dive: Gen Z women are struggling the most with stress, mental health issues

In five points, we break down how people around the world are dealing (or not) as the pandemic fades away, war grinds on and sticky inflation sticks around.
Healthcare Publication

Mastering complexity: The path towards a cancer-free reality

This is the third and final paper in a series which began eight years ago, focusing on unravelling – and ultimately overcoming – the sheer complexity of cancer, one of humanity’s oldest and most formidable foes.

Mental health is now the number one health problem, ahead of cancer and coronavirus

48% across 31 countries say the quality of the healthcare in their country is good – but the picture is inconsistent.
Healthcare Publication

The omnichannel reality in the Pharmaceutical industry

The role of voice of the customer research and analytics in driving omnichannel success
Healthcare Publication

The doctor-patient relationship in the generative AI era

Five reasons why the time to act for pharma is now.